Dr Antony Rapisarda

CEO and Founder

Inventor of the SynvIchor™ technology based on the ELIJA clinical trial in Queensland, Australia. Previously successful commercialization of SeptiCyte™ technology, for Immunexpress, in Seattle USA. Medical doctor currently training in Orthopaedic Surgery in Australia and PhD candidate in Molecular Genomics at Queensland University of Technology. Over 15 years of tertiary academic research and education combined with unique business opportunities in the USA for equally novel technologies.

Dr Brian Fox

Strategic Bioinformatics Partner

Provider of bioinformatics platform essential to the discovery of the SynvIchor™ technology. Discovered a Pan Viral gene signature while at Immunexpress, in Seattle USA. Currently resides in Seattle and is founder and director of Needle Genomics – a company that utilizes proprietary algorithms to solve clinical diagnostic challenges. PhD graduate of University of Washington, USA followed by nearly 20 years of industry bioinformatics experience.

Mr Carlos Barrera

Director of Operations

Mr Barrera has a strong background in Australian start-up industry. He was instrumental in the successful launch of the ClickView e-learning platform, which won BRW’s most innovative company in 2012. Currently operations manager at BasisPoint Consulting – a company that provides business intelligence and networking opportunities for participants in the investment & financial markets. Mr Barrera brings over 12 years experience of IT expertise, operations and product management to the team.

Mr David Cardona

Director of IT

Mr Cardona brings 22 years of IT experience and technical leadership to the team. With a proven track record of delivering solutions across software, hardware and platform architecture, software engineering, data management and development operations. With a keen focus in artificial intelligence and machine learning David has seen the successful architecture, development and delivery of critical systems within laboratory information, robotics, manufacturing, finance and  ecommerce technologies.

Mr Luke Holtom

Chief Financial Officer

Mr Holtom is a CA (Chartered Accountant) qualified specialized in commercial banking and insolvency. Successful winner of the Ferrier Hodgson internship program, Mr Holtom leveraged this career start into a successful transition to major UK banking organisations. With his experience of insolvency accounting he was brought into LLoyds bank and tasked with working in the large M&A space including preparation for audit.

Dr Robert Johnson

Senior Clinical Research Associate

Medical doctor with 5+ years research experience in sports medicine and inflammatory myositis. He has a keen interest in investment strategy and business development and is based in the tropical regions of Queensland, Australia. Winner of the BridgeTech Pitching Competition, Australia in 2019 and finalist for same in Boston, USA. Robert excels at developing key relationships with clinicians and investors alike. Robert has represented Australia in the sports of Olympic Weightlifting and Athletics including competing at world championships for his pet event Hammer throw.